PREVAIL THERAPEUTICS INC- CVR's ticker is and the CUSIP is 532CVR108. A total of 1 filers reported holding PREVAIL THERAPEUTICS INC- CVR in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 13,291 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | – | 13,291 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 13,291 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 13,291 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 13,291 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 13,291 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 13,291 | -1.1% | 0.00% | – |
| Q4 2021 | $0 | – | 13,444 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 13,444 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 13,444 | -5.4% | 0.00% | – |
| Q1 2021 | $0 | – | 14,214 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHUMBLINE ADVISERS | 13,291 | $0 | 0.00% |